ClinVar Miner

Submissions for variant NM_031263.4(HNRNPK):c.676_678del (p.Asp226del)

dbSNP: rs1956875321
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001267557 SCV001445738 likely pathogenic Inborn genetic diseases 2020-09-30 criteria provided, single submitter clinical testing The c.676_678delGAT (p.D226del) alteration, located in exon 11 (coding exon 9) of the HNRNPK gene, results from an in-frame 3 nucleotide deletion at positions 676 to 678. This results in the deletion of an aspartic acid (D) residue at codon 226. Based on data from the Genome Aggregation Database (gnomAD), the HNRNPK c.676_678delGAT alteration was not observed, with coverage at this position. This alteration has been identified as a de novo event in multiple individuals (Ambry internal data). The p.D226 amino acid is conserved in available vertebrate species. The p.D226del alteration is predicted to be deleterious with a score of -12.372 by PROVEAN in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.